Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
57
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Comparing efficacy and survivals of initial treatments for elderly patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials

Xiaoping Liu1 Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University
,
Jiarui Chen2 School of Basic Medical Science, Wuhan University, Wuhan, Hubei, People’s Republic of China
,
Yuncen A He3 School of Medicine, Case Western Reserve University, Cleveland, OH, USA
,
Xiangyu Meng1 Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University
,
Kaili Li4 Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China
,
Colin K He5 Orient Healthcare, New York, NY, USACorrespondence[email protected]
&
Shangqin Liu4 Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 121-128 | Published online: 22 Dec 2016

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Karthik Ramasamy, Sujith Dhanasiri, Howard Thom, Vanessa Buchanan, Suzanne Robinson, Vijay K. D’Souza & Katja Weisel. (2020) Relative efficacy of treatment options in transplant-ineligible newly diagnosed multiple myeloma: results from a systematic literature review and network meta-analysis. Leukemia & Lymphoma 61:3, pages 668-679.
Read now

Articles from other publishers (4)

Szabolcs Kiss, Noémi Gede, Alexandra Soós, Péter Hegyi, Bettina Nagy, Marcell Imrei, Bernadett Czibere, Nelli Farkas, Lilla Hanák, Zsolt Szakács, Bálint Eröss & Hussain Alizadeh. (2021) Efficacy of first-line treatment options in transplant-ineligible multiple myeloma: A network meta-analysis. Critical Reviews in Oncology/Hematology 168, pages 103504.
Crossref
Vanessa Piechotta, Tina Jakob, Peter Langer, Ina Monsef, Christof Scheid, Lise J Estcourt, Sunday Ocheni, Sebastian Theurich, Kathrin Kuhr, Benjamin Scheckel, Anne Adams & Nicole Skoetz. (2019) Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis. Cochrane Database of Systematic Reviews 2020:8.
Crossref
Leo Sekine, Patrícia Klarmann Ziegelmann, Denise Manica, Carolina da Fonte Pithan, Monalisa Sosnoski, Vinicius Daudt Morais, Frederico Soares Falcetta, Mariana Rangel Ribeiro, Ana Paula Salazar & Rodrigo Antonini Ribeiro. (2019) Upfront treatment for newly diagnosed transplant-ineligible multiple myeloma patients: A systematic review and network meta-analysis of 14,533 patients over 29 randomized clinical trials. Critical Reviews in Oncology/Hematology 143, pages 102-116.
Crossref
Xiao-Ping Liu, Xiao-Hong Yin, Xiang-Yu Meng, Xin-Hui Yan, Fan Wang & Li He. (2019) Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma. Frontiers in Oncology 8.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.